2023³âµµ ´ëÇÑÁ¤½Å¾à¹°ÇÐȸ Çϰ迬¼ö±³À° : 2023-06-09
±³À°ÀÏÀÚ : 2023-06-09
±³À°Àå¼Ò : ¼¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ
±³À°ÁÖÁ¦ : 2023³âµµ ´ëÇÑÁ¤½Å¾à¹°ÇÐȸ Çϰ迬¼ö±³À°
ÁÖÃÖ±â°ü : ´ëÇÑÁ¤½Å¾à¹°ÇÐȸ
´ã´çÀÚ : À̼¼Àº
¿¬¶ôó : 02-784-2742
À̸ÞÀÏ : secretariat@kcnp.or.kr
±³À°Á¾·ù : Á¤½Å°Ç°ÀÇÇаú
Âü¼®¿¹»óÀÎ : 150¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 60,000¿ø
ºñ°í »çÀüµî·Ïºñ Æò»ýȸ¿ø ¸éÁ¦/Á¤È¸¿ø 30,000¿ø/ºñȸ¿ø 50,000¿ø/ÁØȸ¿ø¹×±âŸ 20,000¿ø/´çÀϵî·Ïºñ Æò»ýȸ¿ø 10,000¿ø/Á¤È¸¿ø 40,000¿ø/ºñȸ¿ø 60,000¿ø/ÁØȸ¿ø ¹× ±âŸ 30,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06¿ù 09ÀÏ ÄÁº¥¼ÇȦ 10:00~10:25 Systematic review and network meta-analysis in antidepressants ¿ì¿µ¼·(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06¿ù 09ÀÏ ÄÁº¥¼ÇȦ 10:25~10:50 Systematic review and meta-analysis of antipsychotics in schizophrenia ½ÅöÁø(°í·ÁÀÇ´ë)
±³À°½Ã°£ 06¿ù 09ÀÏ ÄÁº¥¼ÇȦ 10:50~11:15 Efficacy of treatments for anxiety disorders: A meta-analysis ¿Õ¼º¹Î(°¡Å縯ÀÇ´ë)
ÈÞ½Ä 06¿ù 09ÀÏ 11:15~11:25 ()
±³À°½Ã°£ 06¿ù 09ÀÏ ÄÁº¥¼ÇȦ 11:25~11:50 Antipsychotics ¾çÂù¸ð(¿ø±¤ÀÇ´ë)
±³À°½Ã°£ 06¿ù 09ÀÏ ÄÁº¥¼ÇȦ 11:50~12:15 Antidepressants À̹®¼ö(°í·ÁÀÇ´ë)
±³À°½Ã°£ 06¿ù 09ÀÏ ÄÁº¥¼ÇȦ 12:15~12:40 Mood stabilizers and anxiolytics ±è½Â°ï(Á¶¼±ÀÇ´ë)
½Ä»ç 06¿ù 09ÀÏ 12:40~13:40 ()
±³À°½Ã°£ 06¿ù 09ÀÏ ÄÁº¥¼ÇȦ 13:40~14:05 Valproate for women of childbearing age ÀÌÁ¤±¸(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 06¿ù 09ÀÏ ÄÁº¥¼ÇȦ 14:05~14:30 Antidepressants for bipolar depression ½ÉÀÎÈñ(µ¿³²±Ç¿øÀÚ·ÂÀÇÇпø)
±³À°½Ã°£ 06¿ù 09ÀÏ ÄÁº¥¼ÇȦ 14:30~14:55 Medication for children ¼ºÇü¸ð(¼øõÇâÀÇ´ë)
ÈÞ½Ä 06¿ù 09ÀÏ 14:55~15:05 ()
±³À°½Ã°£ 06¿ù 09ÀÏ ÄÁº¥¼ÇȦ 15:05~15:30 ¼ö¸é°Ë»ç½ÇÀÇ ¿î¿µ ¹× ¼ö¸éÀü¹® Ä¡·á ±èÀçÇÏ(¼û¼ö¸éŬ¸®´Ð)
±³À°½Ã°£ 06¿ù 09ÀÏ ÄÁº¥¼ÇȦ 15:30~15:55 qEEG¿Í rTMS ±×¸®°í tDCS: ¾î¶² ȯÀÚ¿¡°Ô ¾î¶»°Ô Àû¿ëÇÏ°í ÀÖ³ª? ¾ç¿ëÁØ(¿À´ÃÁ¤½Å°Ç°ÀÇÇаú)
±³À°½Ã°£ 06¿ù 09ÀÏ ÄÁº¥¼ÇȦ 15:55~16:20 Esketamine nasal spray¿Í Àå±âÁö¼ÓÇü ÁÖ»çÁ¦(LAI) ¼Û¹Î±Ô(¼º¸ð°ø°¨Á¤½Å°Ç°ÀÇÇаú)